Sanofi
From a strategic French initiative to a global pharmaceutical powerhouse, Sanofi's journey is a saga of innovation, resilience, and enduring impact.
Quick Facts
- Founded
- 1973
- Founder
- French government initiative
- Origin
- France
Founders
Story Chapters
Timeline
Sanofi Founded
Sanofi was established by a French government initiative to foster innovation in the pharmaceutical industry, marking the beginning of a global healthcare leader.
Merger with Synthélabo
Sanofi merged with Synthélabo, a major pharmaceutical company, enhancing its research capabilities and expanding its global reach.
Acquisition of Aventis
Sanofi acquired Aventis, creating one of the largest pharmaceutical companies in the world and significantly boosting its product portfolio.
Acquisition of Zentiva
Sanofi acquired Zentiva, strengthening its generics business and increasing its presence in emerging markets.
Acquisition of Genzyme
Sanofi acquired Genzyme, a leader in biotechnology, to enhance its capabilities in rare diseases and biotechnology.
Launch of Toujeo
Sanofi launched Toujeo, a next-generation insulin product, reinforcing its leadership in diabetes care.
Partnership with Regeneron
Sanofi and Regeneron Pharmaceuticals announced a strategic partnership to develop and commercialize new immuno-oncology treatments.
Acquisition of Bioverativ
Sanofi acquired Bioverativ, a company focused on hemophilia and rare blood disorders, to expand its rare disease portfolio.
COVID-19 Vaccine Development
Sanofi engaged in the global effort to develop a COVID-19 vaccine, leveraging its expertise in vaccine development.
Acquisition of Amunix
Sanofi acquired Amunix Pharmaceuticals to enhance its oncology pipeline with innovative T-cell engager and cytokine therapies.
Connected Across The Archives
Explore specific connections to other archives—civilizations, conflicts, dynasties, and treaties that share history with this company.
Civilization Archive
(3)Austrian Empire
Sanofi's founding in 1973 occurred as traditional empires waned, creating a new European market landscape for pharmaceutical innovation and expansion.
European Union Civilization
Sanofi's growth trajectory was molded by the EU's regulatory frameworks, reflecting post-1993 European integration's impact on pharmaceutical innovation and market expansion.
French Colonial Civilization
Sanofi's emergence in 1973 was influenced by France's colonial legacy, which shaped its global pharmaceutical strategies and market expansion.
Explore Related Archives
Great companies don't emerge in a vacuum. They rise from the foundations of civilizations, the ambitions of rulers, and the aftermath of conflicts. Explore the historical context:
